viragen inc said will start expanded study its alpha interferon topical ointment for treatment genital herpes said will conduct phase iii study two different dosage forms treatment and compare placebo nonmedicated substitute least 154 men and women viragen said study results expected october 1987 viragen said prepared submit license applications for ointment england canada and west germany addition when phase iii study completed reuter 